Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening

Zhou,Shuliang; Xiao,Youde; Zhuang,Yafei; Liu,Yinyin; Zhao,Hong; Yang,Hui; Xie,Conghua; Zhou,Fuxiang; Zhou,Yunfeng

doi:10.3892/or.2017.5707

Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening

Authors:
- Shuliang Zhou
- Youde Xiao
- Yafei Zhuang
- Yinyin Liu
- Hong Zhao
- Hui Yang
- Conghua Xie
- Fuxiang Zhou
- Yunfeng Zhou
View Affiliations

Affiliations: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: June 6, 2017 https://doi.org/10.3892/or.2017.5707
Pages: 515-521

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Homeobox containing 1 (HMBOX1) modulates telomere length in various types of tumor cells by binding to double‑stranded telomeric DNA. There is a negative correlation between telomere length and radiosensitivity in tumor cells. In the present study, we aimed to investigate the relationship among HMBOX1, telomere and radiosensitivity in cervical cancer cells. Lentivirus-based shRNAs were used to establish stable transfected cell lines in which protein and mRNA levels of HMBOX1 were notably decreased. Knockdown of HMBOX1 increased the radiosensitivity of HeLa and C33A cells. TERT protein was also decreased while HMBOX1 was downregulated. Knockdown of HMBOX1 shortened telomere length in the HeLa cells, while TERT overexpression rescued telomere shortening in the HeLa-HMBOX1 cells. Knockdown of HMBOX1 increased the apoptosis rate, decreased radiation-induced DNA damage foci, and inhibited the expression of ATM, ATR, p-ATM, p-ATR and BRCA1 in the homologous recombination repair pathway. Our data suggest a possible role of HMBOX1 in regulating radiosensitivity in cervical cancer cells. Moreover, HMBOX1 may be a potential factor in the radiotherapy of cervical cancer.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Zuliani AC, Esteves SC, Teixeira LC, Teixeira JC, de Souza GA and Sarian LO: Concomitant cisplatin plus radiotherapy and high-dose-rate brachytherapy versus radiotherapy alone for stage IIIB epidermoid cervical cancer: A randomized controlled trial. J Clin Oncol. 32:542–547. 2014. View Article : Google Scholar : PubMed/NCBI
3	Chen S, Saiyin H, Zeng X, Xi J, Liu X, Li X and Yu L: Isolation and functional analysis of human HMBOX1, a homeobox containing protein with transcriptional repressor activity. Cytogenet Genome Res. 114:131–136. 2006. View Article : Google Scholar : PubMed/NCBI
4	Déjardin J and Kingston RE: Purification of proteins associated with specific genomic Loci. Cell. 136:175–186. 2009. View Article : Google Scholar : PubMed/NCBI
5	Kappei D, Butter F, Benda C, Scheibe M, Draškovič I, Stevense M, Novo CL, Basquin C, Araki M, Araki K, et al: HOT1 is a mammalian direct telomere repeat-binding protein contributing to telomerase recruitment. EMBO J. 32:1681–1701. 2013. View Article : Google Scholar : PubMed/NCBI
6	Feng X, Luo Z, Jiang S, Li F, Han X, Hu Y, Wang D, Zhao Y, Ma W, Liu D, et al: The telomere-associated homeobox-containing protein TAH1/HMBOX1 participates in telomere maintenance in ALT cells. J Cell Sci. 126:3982–3989. 2013. View Article : Google Scholar : PubMed/NCBI
7	Palm W and de Lange T: How shelterin protects mammalian telomeres. Annu Rev Genet. 42:301–334. 2008. View Article : Google Scholar : PubMed/NCBI
8	de Lange T: Protection of mammalian telomeres. Oncogene. 21:532–540. 2002. View Article : Google Scholar : PubMed/NCBI
9	Blackburn EH: Switching and signaling at the telomere. Cell. 106:661–673. 2001. View Article : Google Scholar : PubMed/NCBI
10	McIlrath J, Bouffler SD, Samper E, Cuthbert A, Wojcik A, Szumiel I, Bryant PE, Riches AC, Thompson A, Blasco MA, et al: Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61:912–915. 2001.PubMed/NCBI
11	Mirjolet C, Boidot R, Saliques S, Ghiringhelli F, Maingon P and Créhange G: The role of telomeres in predicting individual radiosensitivity of patients with cancer in the era of personalized radiotherapy. Cancer Treat Rev. 41:354–360. 2015. View Article : Google Scholar : PubMed/NCBI
12	Yang H, Wu L, Ke S, Wang W, Yang L, Gao X, Fang H, Yu H, Zhong Y, Xie C, et al: Downregulation of ubiquitin-conjugating enzyme UBE2D3 promotes telomere maintenance and radioresistance of Eca-109 human esophageal carcinoma cells. J Cancer. 7:1152–1162. 2016. View Article : Google Scholar : PubMed/NCBI
13	Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res. 30:e472002. View Article : Google Scholar : PubMed/NCBI
14	Gao X, Wang W, Yang H, Wu L, He Z, Zhou S, Zhao H, Fu Z, Zhou F and Zhou Y: UBE2D3 gene overexpression increases radiosensitivity of EC109 esophageal cancer cells in vitro and in vivo. Oncotarget. 7:32543–32553. 2016.PubMed/NCBI
15	Franken NA, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
16	d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP and Jackson SP: A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:194–198. 2003. View Article : Google Scholar : PubMed/NCBI
17	Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M and Bonner WM: A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 10:886–895. 2000. View Article : Google Scholar : PubMed/NCBI
18	Shiloh Y: ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer. 3:155–168. 2003. View Article : Google Scholar : PubMed/NCBI
19	Drissi R, Wu J, Hu Y, Bockhold C and Dome JS: Telomere shortening alters the kinetics of the DNA damage response after ionizing radiation in human cells. Cancer Prev Res. 4:1973–1981. 2011. View Article : Google Scholar
20	Yang L, Wang W, Hu L, Yang X, Zhong J, Li Z, Yang H, Lei H, Yu H, Liao Z, et al: Telomere-binding protein TPP1 modulates telomere homeostasis and confers radioresistance to human colorectal cancer cells. PLoS One. 8:e810342013. View Article : Google Scholar : PubMed/NCBI
21	Tribius S, Pidel A and Casper D: ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys. 50:511–523. 2001. View Article : Google Scholar : PubMed/NCBI
22	Rainey MD, Charlton ME, Stanton RV and Kastan MB: Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation. Cancer Res. 68:7466–7474. 2008. View Article : Google Scholar : PubMed/NCBI
23	Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH and Li Y: PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis. 5:e14372014. View Article : Google Scholar : PubMed/NCBI
24	Alao JP and Sunnerhagen P: The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation. Radiat Oncol. 4:512009. View Article : Google Scholar : PubMed/NCBI
25	Zhu WG, Seno JD, Beck BD and Dynlacht JR: Translocation of MRE11 from the nucleus to the cytoplasm as a mechanism of radiosensitization by heat. Radiat Res. 156:95–102. 2001. View Article : Google Scholar : PubMed/NCBI
26	Loayza D and De Lange T: POT1 as a terminal transducer of TRF1 telomere length control. Nature. 423:1013–1018. 2003. View Article : Google Scholar : PubMed/NCBI
27	Ma H, Su L, Yue H, Yin X, Zhao J, Zhang S, Kung H, Xu Z and Miao J: HMBOX1 interacts with MT2A to regulate autophagy and apoptosis in vascular endothelial cells. Sci Rep. 5:151212015. View Article : Google Scholar : PubMed/NCBI
28	Ribero S, Sanna M, Visconti A, Navarini A, Aviv A, Glass D, Spector TD, Smith C, Simpson M, Barker J, et al: Acne and telomere length: A new spectrum between senescence and apoptosis pathways. J Invest Dermatol. 137:513–515. 2017. View Article : Google Scholar : PubMed/NCBI
29	Wang Y, Wang X, Flores ER, Yu J and Chang S: Dysfunctional telomeres induce p53-dependent and independent apoptosis to compromise cellular proliferation and inhibit tumor formation. Aging Cell. 15:646–660. 2016. View Article : Google Scholar : PubMed/NCBI
30	Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, et al: Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature. 394:287–291. 1998. View Article : Google Scholar : PubMed/NCBI
31	Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z and Kolesnick R: Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 300:1155–1159. 2003. View Article : Google Scholar : PubMed/NCBI
32	Meng MB, Jiang XD, Deng L, Na FF, He JZ, Xue JX, Guo WH, Wen QL, Lan J, Mo XM, et al: Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: Experimental and clinical evidence. Radiother Oncol. 106:130–137. 2013. View Article : Google Scholar : PubMed/NCBI